NOTICE of Intent to SOLE SOURCE - Fisher Scientific
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), under the Department of Health and Human Services, has issued a Notice of Intent to Sole Source to Fisher Scientific. This notice is for the purchase of high-magnification objectives (20x and 40x) and a laser autofocusing module for the Agilent BioTek Cytation 1 Cell Imaging Multi-Mode Reader. The purpose is to acquire specialized equipment for the CDC's research needs in Atlanta, GA. Interested parties who believe they can provide these items must submit their capabilities by June 30, 2026.
Scope of Requirement
The CDC intends to procure specific components to enhance an existing Agilent BioTek Cytation 1 Cell Imaging Multi-Mode Reader. The required items include:
- High-magnification objectives (20x and 40x)
- A laser autofocusing module These components are essential for advanced cell imaging and analysis within the CDC's research facilities at the place of performance in Atlanta, GA.
Contract & Timeline
- Type: Special Notice (Notice of Intent to Sole Source)
- Intended Vendor: Fisher Scientific
- Set-Aside: Not applicable (Sole Source)
- Response Due: June 30, 2026, 12:00 PM ET
- Published: June 15, 2026
Additional Information
This notice serves as an announcement of the CDC's intent to award a sole source contract to Fisher Scientific. However, other responsible sources may identify their interest and capability to provide the required items. Responses should clearly demonstrate the ability to meet the specified requirements. All inquiries should be directed to Marcus Lindsey at yzg2@cdc.gov or 770-488-5242.